Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.4000 (12.68%) ($6.1000 - $7.5000) on Tue. Apr. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.82% (three month average) | RSI | 69 | Latest Price | $6.4000(12.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) UNG(11%) BNDX(9%) TLT(9%) BWX(7%) PCY(7%) | Factors Impacting CAPR price | CAPR will decline at least -3.41% in a week (0% probabilities). XME(-23%) XHB(-22%) XRT(-21%) URA(-20%) IVW(-20%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.41% (StdDev 6.82%) | Hourly BBV | 0 () | Intraday Trend | 3.2% | | | |
|
5 Day Moving Average | $5.6(14.29%) | 10 Day Moving Average | $5.65(13.27%) | 20 Day Moving Average | $5.31(20.53%) | To recent high | -5.9% | To recent low | 28% | Market Cap | $126m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |